Evaluation of DCTclock™ as a Cognitive Assessment Aid

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

450 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-07-11

Study Completion Date

2017-11-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The overall objective of this study is to demonstrate the safety and effectiveness of DCTclock as an adjunctive tool for use by clinicians to evaluate cognitive function in adults aged 55-95.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Identification of Predictors for Early Cognitive Decline in Men

NCT03290040

Healthy Test Persons Mild Cognitive Impairment Alzheimer Disease

COMPLETED

Cerebral Haemodynamic Changes During Cognitive Testing: A fTCD Study

NCT03134963

Mild Cognitive Impairment Alzheimer Disease Vascular Dementia +1 more

COMPLETED

Normative Database and Test-Retest Reliability for BrainCheck Assessments

NCT05497427

Cognitive Change Cognitive Decline Cognitive Deterioration +1 more

COMPLETED

Cognitive Screening and Cognitive Training in Seniors

NCT02588209

Mild Cognitive Impairment

COMPLETED NA

Digital Evaluations and Technologies Enabling Clinical Translation for AD

NCT05385913

Alzheimer Disease, Early Onset

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cognitive Function

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

This study uses a paired design in which each subject undergoes blinded testing by separate testers administering DCTclock and a battery of reference standard tests to determine cognitive state.

Primary Study Purpose

SCREENING

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

All qualified participants

Participants received DCTclock, Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), and a battery of other traditional pen and paper neuropsychological assessments.

Group Type EXPERIMENTAL

DCTclock

Intervention Type DEVICE

DCTclock is a quick and non-invasive test that measures cognitive function based on a computerized algorithmic analysis of the entire drawing process and output of a well-established cognitive assessment called The Clock Drawing Test (CDT).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

DCTclock

DCTclock is a quick and non-invasive test that measures cognitive function based on a computerized algorithmic analysis of the entire drawing process and output of a well-established cognitive assessment called The Clock Drawing Test (CDT).

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Men and women 55 to 95 years old.

Exclusion Criteria

* Ineligible for written informed consent.
* Physical impairment of the writing hand.
* Impaired manual dexterity.
* Impaired vision.
* Under the influence of recreational drugs or alcohol at the time of the visit.
* Current or recent participation in a clinical trial that includes the use of a drug or intervention to alter cognitive function.
* Recent cognitive testing.

Minimum Eligible Age

55 Years

Maximum Eligible Age

95 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes